recent articles
CAMBRIDGE, Mass., July 14, 2022 /PRNewswire/ -- VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that VistaPath Sentinel was validated in a clinical setting...
CAMBRIDGE, Mass., June 30, 2022 /PRNewswire/ -- VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that it has secured $4 million in seed funding led by...
The world’s first Artificial Intelligence (AI) software that can accurately perform breast cancer diagnosis has received approval for implementation in the UK and EU. The breast cancer diagnosis technology – called PANProfiler – has been...
Israeli AI Cancer Startup Lands $5 Million
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- File format
- Image Analysis
- Informatics
- International
- Laboratory Informatics
- Medical Research
- New Digital Imaging Technologies
- Pathology News
- Science
- Vendor products
In the latest round of AI funding, Israeli startup, Nucleai raised $5 million in seed round led by Vertex Ventures Israel and Grove Ventures Capital (GP) Ltd. Nucleai, a Tel Aviv-based startup, is developing an AI pathology system to help...